• Waldenström Macroglobulinemia
  • Melanoma
  • Bladder Cancer
  • Brain Cancer
  • Breast Cancer
  • Childhood Cancers
  • Gastric Cancer
  • Gynecologic Cancer
  • Head & Neck Cancer
  • Immunotherapy
  • Kidney Cancer
  • Leukemia
  • Liver Cancer
  • Lung Cancer
  • Lymphoma Cancer
  • Mesothelioma
  • MPN
  • MDS
  • Myeloma
  • Prostate Cancer
  • Rare Cancers
  • Sarcoma
  • Skin Cancer
  • Testicular Cancer
  • Thyroid Cancer

Episode 31: Bladder Cancer Matters Podcast How COVID Changed How Bladder Cancer Doctors and Patients Interact with Dr. Sima Porten


In Episode 31 of Bladder Cancer Matters, host Rick Bangs talks with Dr. Sima Porten, a urologic cancer surgeon at the University of California San Francisco, about how COVID changed the way that bladder cancer doctors and patients interact.

Rick and Dr. Porten talk about:

  • Some of the experiences of patients during the COVID-19 pandemic
  • How medical distancing impacted Dr. Porten personally as well as her colleagues
  • How she used telemedicine during the pandemic
  • The use of in-home tests for bladder cancer that used to be done in a doctor’s office
  • Disparities in bladder cancer medical care
  • How COVID impacted bladder cancer clinical trial operations

Disclaimer: The views and opinions expressed in this podcast are those of the speakers and guests and do not necessarily reflect the views or positions of the Bladder Cancer Advocacy Network.


Related Videos
Kristie L. Kahl and Dr. Tracy L. Rose
Dr. Tracy Rose
Dr. Tracy L. Rose
Kristie L. Kahl and Tracy L. Rose
Kristie L. Kahl